However, a 30% reduction was seen in the composite adverse outcome for foetal and maternal complications (p¼ 0.01).
OBJECTIVE:
The objective of the study was to verify the appearance of signs of suspected Triple I and the progressive involvement of placenta according to Redline classification of chorionamnionitis (CHA) and to understand the impact of CHA on maternal and neonatal outcome STUDY DESIGN: A retrospective cohort study of histological placental analysis obtained after term pregnancies between 2014-2017 at Carate Brianza Hospital, University of Milano-Bicocca. Included were all cases of HCA. The diagnosis of maternal fever (T ) and suspected intraamniotic inflammation, infection or both was made according to Triple I classification (IAI). Maternal adverse outcomes were defined as postpartum haemorrhage, endometritis or composite bad outcome (Mbad) including fever after hospital discharge and/or prolonged antibiotic therapy. Neonatal adverse outcomes were defined as asphyxia, positive blood culture, high CRP or composite bad outcome (Nbad) including admission to NICU and/ or prolonged antibiotic therapy. Histological CHA was stadiated for severity according to Redline classification. Analyses were conducted by SPSSÒ 24.0; p-value <0.05 was considered significant RESULTS: Among 6,962 deliveries, 1,314 placentas of which 1,122 at term, were analysed, 32.4 % due to signs of IAI in labour . 339 of placentas had HCA and 133 (39.2%) of them had a whole inflammatory involvement (PLw). The presence of T plus all 3 other clinical signs of IAI (all T ) was significantly related to stage 1 (p<0.01), stage 2 (p<0.05) of maternal inflammatory placental involvement (PLm) moreover to stage 1 (p<0.01), stage 2 (p<0.02), stage 3 (p<0.01) of fetal inflammatory placental involvement (PLf). (Table 2) . CONCLUSION: Women with 2 prior cesareans had lower VBAC success than those with 1 prior cesarean, but most women attempting TOLAC in both groups were successful. Uterine rupture and maternal composite morbidity was similar between women with 2 prior and 1 prior cesarean deliveries, but those with 2 cesareans had Poster Session IV Comparisons were made among the groups using multivariable logistic regression, controlling for maternal age, race, parity and body mass index.
RESULTS:
The CSL data includes 228,438 deliveries. Based on our inclusion criteria, 29,087 were included in our analysis. There is a 1.57 fold higher odds of an adverse neonatal outcome with labor lasting >9 hours compared to the 0-2 hours group (p-value <0.001, 95% CI 1.2-1.9). All groups demonstrated significantly increased odds for adverse maternal outcome compared to 0-2 hours. Any active labor length >4 hours has increased odds of either an adverse maternal or neonatal outcome compared to 0-2 hours. CONCLUSION: Recent NICHD guidelines regarding labor management utilizing contemporary labor curves have not analyzed risk of adverse perinatal outcomes to date. Therefore, our data uniquely demonstrates that a longer duration of contemporary active labor is associated with adverse maternal and neonatal outcomes. While longer duration of active labor is allowed in current NICHD guidelines with the goal to reduce cesarean delivery, our data suggests that further studies are needed to evaluate safe and effective management of active labor to optimize maternal and neonatal health.
